tiprankstipranks
Trending News
More News >
Blueprint Medicines Corp. (BPMC)
NASDAQ:BPMC
Advertisement

Blueprint Medicines (BPMC) Similar Stocks

Compare
609 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Blueprint Medicines
$129.46
$8.37B
38.47%
2 Buy
16 Hold
0 Sell
Hold
Alkermes
$29.05
$4.67B
13.57
7.67%
9 Buy
5 Hold
0 Sell
Moderate Buy
Sarepta Therapeutics
$21.81
$1.98B
19.61
-83.64%
6 Buy
19 Hold
5 Sell
Hold
Axsome Therapeutics
$109.22
$5.43B
27.57%
16 Buy
1 Hold
0 Sell
Strong Buy
BridgeBio Pharma
$51.32
$9.78B
110.33%
17 Buy
2 Hold
0 Sell
Strong Buy
Revolution Medicines
$36.32
$6.73B
-16.54%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BPMC
Blueprint Medicines
129.46
35.97
38.47%
ALKS
Alkermes
29.05
1.80
6.61%
SRPT
Sarepta Therapeutics
21.81
-111.65
-83.66%
AXSM
Axsome Therapeutics
109.22
23.05
26.75%
BBIO
BridgeBio Pharma
51.32
26.92
110.33%
RVMD
Revolution Medicines
36.32
-6.53
-15.24%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis